+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Production and characterization of specific monoclonal antibodies binding the Plasmodium falciparum diagnostic biomarker, histidine-rich protein 2



Production and characterization of specific monoclonal antibodies binding the Plasmodium falciparum diagnostic biomarker, histidine-rich protein 2



Malaria Journal 13: 277



Early and accurate diagnosis of Plasmodium falciparum infection is important for providing appropriate treatment to patients with malaria. However, technical limitations of currently available diagnostic tests limit their use in control programs. One possible explanation for the vulnerability of current antibodies used in RDTs is their propensity to degrade at high ambient temperatures. Isolation of new antibodies with better thermal stability represents an appealing approach to improve the performance of RDTs. In this study, phage display technology was deployed to isolate novel binders by screening a human naïve scFv antibody library against recombinant Plasmodium falciparum histidine rich protein 2 (rPfHRP2). The isolated scFv clones were reformatted to whole IgG and the recombinant mAbs were produced in a mammalian CHO cell expression system. To verify the biological activity of these purified recombinant mAbs, range of functional assays were characterized. Two unique clones (D2 and F9) were isolated after five rounds of biopanning. The reformatted and expressed antibodies demonstrated high binding specificity to malaria recombinant PfHRP2 and native proteins. When 5 μg/mL of mAbs applied, mAb C1-13 had the highest sensitivity, with an OD value of 1, the detection achieved 5 ng/mL of rPfHRP2, followed by mAbs D2 and F9 at 10 ng/mL and 100 ng/mL of rPfHRP2, respectively. Although the sensitivity of mAbs D2 and F9 was lower than the control, these recombinant human mAbs have shown better stability compared to mouse mAb C1-13 at various temperatures in DSC and blot assays. In view of epitope mapping, the predominant motif of rPfHRP2 recognized by mAb D2 was AHHAADAHHA, whereas mAb F9 was one amino acid shorter, resulting in AHHAADAHH. mAb F9 had the strongest binding affinity to rPfHRP2 protein, with a KD value of 4.27 × 10(-11) M, followed by control mAb C1-13 at 1.03 × 10(-10) M and mAb D2 at 3.05 × 10(-10) M. Overall, the performance of these mAbs showed comparability to currently available PfHRP2-specific mouse mAb C1-13. The stability of these novel binders indicate that they merit further work to evaluate their utility in the development of new generation point of care diagnosis of malaria.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 055199473

Download citation: RISBibTeXText

PMID: 25037150

DOI: 10.1186/1475-2875-13-277


Related references

Effect of sequence variation in Plasmodium falciparum histidine- rich protein 2 on binding of specific monoclonal antibodies: Implications for rapid diagnostic tests for malaria. Journal of Clinical Microbiology 44(8): 2773-2778, 2006

Development, purification, and characterization of monoclonal antibodies against recombinant histidine-rich protein 3 of Plasmodium falciparum. Monoclonal Antibodies in Immunodiagnosis and ImmunoTherapy 32(5): 341-348, 2013

Novel monoclonal antibodies against Plasmodium falciparum histidine-rich protein 2: development and application in rapid diagnostic tests of malaria in hyperendemic regions of China and Myanmar. Bmc Microbiology 15: 98, 2015

Monoclonal antibodies against recombinant histidine-rich protein 2 of Plasmodium falciparum and their use in malaria diagnosis. Hybridoma 30(6): 519-524, 2011

The purification of histidine-rich protein II of Plasmodium falciparum and preparation of its polyclonal and monoclonal antibodies. Journal of Tropical Medicine Guangzhou 2(1): 21-23, 2002

Recombinant antibodies specific for the Plasmodium falciparum histidine-rich protein 2. Mabs 2(4): 416-427, 2015

Variation in Plasmodium falciparum Histidine-Rich Protein 2 (Pfhrp2) and Plasmodium falciparum Histidine-Rich Protein 3 (Pfhrp3) Gene Deletions in Guyana and Suriname. Plos one 10(5): E0126805, 2015

Spectroscopic characterization of the heme-binding sites in Plasmodium falciparum histidine-rich protein 2. Biochemistry 38(51): 16916-16924, 1999

Reactivity of a monoclonal antibody produced to the histidine-rich protein of Plasmodium lophurae with Plasmodium falciparum. Molecular and Biochemical Parasitology 172: 155-162, 1985

Variation in the histidine-rich protein 2 of Plasmodium falciparum: implications for the performance of rapid diagnostic tests for falciparum malaria.. 2008

Mapping the binding domains involved in the interaction between the Plasmodium falciparum knob-associated histidine-rich protein and the cytoadherence ligand P falciparum erythrocyte membrane protein 1. Journal of Biological Chemistry 274(34): 23808-23813, 1999

Plasmodium falciparum: production and characterization of rat monoclonal antibodies specific for the sexual-stage Pfs48/45 antigen. Experimental Parasitology 97(1): 45-49, 2001

Mapping the binding domains involved in the interaction between the Plasmodium falciparum knob-associated histidine-rich protein (KAHRP) and the cytoadherence ligand P. falciparum erythrocyte membrane protein 1 (PfEMP1). Journal of Biological Chemistry 274(34): 23808-23813, 1999

Production and characterization of monoclonal antibodies against substrate specific loop region of Plasmodium falciparum lactate dehydrogenase. Immunological Investigations 43(6): 556-571, 2014

Heme binding to the histidine-rich protein II from Plasmodium falciparum. Biochemistry 44(3): 979-986, 2005